IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is trading at $37.86, about ₹3,637 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 0.94% today. Indian residents can buy IDEAYA Biosciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$37.21
Today's high
$38.28
52 week low
$26.05
52 week high
$42.68
IDYA opened at $38.14, closed previously at $38.22, and has traded between $26.05 and $42.68 over the past 52 weeks.
About
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltransferase 2a (MAT2A) blocking agent, is currently in early-stage (Phase I) trials for solid tumors exhibiting methylthioadenosine phosphorylase (MTAP) deletions. Its second primary candidate, IDE196, a protein kinase C (PKC) inhibitor, is progressing through Phase I/II studies, targeting genetically defined cancers characterized by GNAQ or GNA11 gene mutations. Beyond its clinical pipeline, IDEAYA's earlier-stage portfolio includes several synthetic lethality programs. These encompass a PARG inhibitor designed to address tumors with specific genetic or molecular biomarkers, Pol Theta inhibitors aimed at cancers presenting with BRCA or other homologous recombination deficiency (HRD) mutations, and WRN inhibitors for tumors demonstrating high microsatellite instability (MSI-H). The company also engages in significant collaborations. It has a joint research effort with Cancer Research UK and the University of Manchester, focusing on small molecule inhibitors of Poly (ADP-ribose) glycohydrolase. Furthermore, IDEAYA maintains a partnership with Pfizer Inc. for the clinical development and supply in Phase I/II trials across metastatic uveal melanoma, skin melanoma, and other solid tumors, alongside a strategic alliance with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was established in 2015 and operates from its headquarters in South San Francisco, California.
Key statistics
Avg. volume
1.00M
Market cap
$3.60B
P/E Ratio
-19.72
Price-to-sales ratio
15.38
Enterprise value
$2.97B
Free cash flow yield
-2.40%
Debt-to-equity ratio
0.02
Return on equity
-11.11%
ROIC
-15.16%
Beta
-0.09
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$218.71M
Earnings per share
-$1.28
Free cash flow
-$73.47M
Net profit margin
-74.75%
Gross margin
-13.32%
EBITDA
-$154.72M
Revenue growth
3024.43%
Similar securities
This is not an investment recommendation
How to buy IDEAYA Biosciences from India
Indian residents can buy IDEAYA Biosciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for IDEAYA Biosciences and place an order
Find IDEAYA Biosciences by name or by its ticker, IDYA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. IDEAYA Biosciences trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your IDEAYA Biosciences position in USD and INR. IDEAYA Biosciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in IDEAYA Biosciences from India
Trading and taxes when buying IDEAYA Biosciences from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneIDEAYA Biosciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy IDEAYA Biosciences stock?
Yes. IDEAYA Biosciences (IDYA) has been listed on NASDAQ since 2019, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one IDEAYA Biosciences share cost in rupees?
One IDEAYA Biosciences share is $37.86 — about ₹3,637 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the IDEAYA Biosciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying IDEAYA Biosciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of IDEAYA Biosciences?
Yes. One IDEAYA Biosciences share is $37.86, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in IDEAYA Biosciences.
How are gains on IDEAYA Biosciences shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the IDEAYA Biosciences price. Paasa issues a capital-gains statement for your return.
Does IDEAYA Biosciences pay a dividend?
No. IDEAYA Biosciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade IDEAYA Biosciences from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on IDEAYA Biosciences shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare IDEAYA Biosciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your IDEAYA Biosciences holding, its cost and its closing value.
How do I sell IDEAYA Biosciences and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.